All Facilities , From 2026-08-31 - 2026-09-15
Intermediate isolates
73
AST results tested
2,243
Overall intermediate
4.6%
Highest rate
Tobramyan (100.0%)
n = 73 Number of Isolates
All Specimens All Organisms
n = 73 Number of Isolates
All Specimens All Organisms
| Antibiotic | Total Tested | Number Intermediate | % Intermediate |
|---|---|---|---|
| Tobramyan | 1 | 1 | 100.0 |
| Doxycline | 4 | 1 | 25.0 |
| Piperacillin | 5 | 1 | 20.0 |
| Doxycycline | 16 | 3 | 18.8 |
| Cefazolin | 6 | 1 | 16.7 |
| Ampicillin/ Sulbactam | 14 | 2 | 14.3 |
| Tobramycin | 7 | 1 | 14.3 |
| Amoxicillin/ Clavulanic acid | 61 | 8 | 13.1 |
| Cefepime | 90 | 10 | 11.1 |
| Penicillin G | 18 | 2 | 11.1 |
| Aztreonam | 19 | 2 | 10.5 |
| Chloramphenicol | 86 | 7 | 8.1 |
| Ciprofloxacin | 163 | 12 | 7.4 |
| Piperacillin/Tazobactam | 129 | 9 | 7.0 |
| Cefoxitin | 51 | 3 | 5.9 |
| Linezolid | 37 | 2 | 5.4 |
| Amikacin | 57 | 3 | 5.3 |
| Ceftazidime | 130 | 6 | 4.6 |
| Tetracycline | 65 | 3 | 4.6 |
| Cefotaxime | 45 | 2 | 4.4 |
| Vancomycin | 48 | 2 | 4.2 |
| Nitrofurantoin | 80 | 3 | 3.8 |
| Erythromycin | 54 | 2 | 3.7 |
| Gentamicin | 203 | 7 | 3.4 |
| Levofloxacin | 64 | 2 | 3.1 |
| Nalidixic acid | 34 | 1 | 2.9 |
| Ceftriaxone | 131 | 3 | 2.3 |
| Imipenem | 102 | 2 | 2.0 |
| Clindamycin | 55 | 1 | 1.8 |
| Ampicillin | 57 | 1 | 1.8 |